NAD+

AWORIS / Products / NAD+

AWORIS

NAD+

Nicotinamide Adenine Dinucleotide (NAD+), 500 mg. Sterile lyophilised powder, manufactured in the EU under GMP conditions. For professional use only — not a ready-to-administer product. Intended for further processing by qualified personnel.

Please sign in to your account and upload your professional license document to view prices.

Active Ingredient: NAD+ (CAS No. 53-84-9)
Form: Sterile lyophilized powder
Content: 500 mg per vial
Purity: >95%
HS Code: 2934999090
Manufacturing: Europe (EU standards)

Store in the dark at 2–8 °C
Shelf life: up to 24 months from date of batch certificate

Nicotinamide Adenine Dinucleotide (NAD+) >95%

INTENDED USE
Supplied as a raw material for further processing by qualified healthcare professionals. Not intended for direct application to humans or distribution to end consumers.

Manufactured in Europe

Clinical-grade

EU-wide delivery

FAQ

AWORIS NAD+ is Nicotinamide Adenine Dinucleotide (NAD+), 500 mg per vial, supplied as a sterile lyophilised powder. It is manufactured in the EU under GMP conditions and intended exclusively for further processing by qualified professionals.

AWORIS products are available exclusively to verified licensed professionals, clinics and commercial processing. Verification of professional credentials or a valid business license is required before pricing and ordering access is granted.

No. AWORIS NAD+ is supplied as a lyophilised raw material powder for further processing by qualified personnel. Lyophilisation (freeze-drying) is a standard pharmaceutical process for substances that are unstable in solution over time. The powder form allows for longer shelf life and is reconstituted at the point of use.

In the European Union (Italy), under GMP (Good Manufacturing Practice) conditions. Full batch documentation is provided with each delivery.

Yes. Every batch is supplied with a Certificate of Analysis documenting purity, sterility, and other specifications. CoAs are available on.

After reconstitution, store at 2–8 °C, protected from light. Use within 28 days. Reconstitution should be performed by qualified personnel under appropriate conditions.

Shipping at room temperature is permitted for the unopened product. Refrigerated storage (2–8 °C) is required upon receipt.

Clinical decisions regarding use, dosing, reconstitution, and administration are the responsibility of the qualified healthcare professional. AWORIS does not provide clinical guidance. Please refer to your own professional judgment and the product documentation supplied with each batch.

See More of our formulas